BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1973717)

  • 1. Exogenous surfactant for treatment of respiratory distress syndrome in premature infants.
    Chen JY
    J Formos Med Assoc; 1990 Feb; 89(2):110-4. PubMed ID: 1973717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
    Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment of very premature infants with human surfactant.
    Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M
    N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
    Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
    Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
    Gortner L
    J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
    Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.
    Hallman M; Merritt TA; Jarvenpaa AL; Boynton B; Mannino F; Gluck L; Moore T; Edwards D
    J Pediatr; 1985 Jun; 106(6):963-9. PubMed ID: 3889259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.
    Charon A; Taeusch W; Fitzgibbon C; Smith GB; Treves ST; Phelps DS
    Pediatrics; 1989 Mar; 83(3):348-54. PubMed ID: 2919139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].
    Gortner L; Bartmann P; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL; Versmold H
    Z Geburtshilfe Perinatol; 1992; 196(4):159-64. PubMed ID: 1413943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.